| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/26/2006 | EP1648496A1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 04/26/2006 | EP1648485A2 Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 04/26/2006 | EP1648473A1 Single dose fast dissolving azithromycin |
| 04/26/2006 | EP1648454A1 Cci-779 lyophilized formulations |
| 04/26/2006 | EP1648442A1 Semi-solid systems containing azetidine derivatives |
| 04/26/2006 | EP1648441A1 Emulsifying systems containing azetidine derivatives |
| 04/26/2006 | EP1648424A2 Non-gelatin film and method and apparatus for producing same |
| 04/26/2006 | EP1648412A1 Microemulsions and its use for preventing airway diseases |
| 04/26/2006 | EP1648410A1 Dialysis solutions with reduced levels of glucose degradation products |
| 04/26/2006 | EP1648406A2 Uses and formulations for transdermal or transmucosal application of active agents |
| 04/26/2006 | EP1648394A1 Method for accelerated administration of carotenoid mixtures in serum and tissues |
| 04/26/2006 | EP1648381A2 Magnetic nanoparticle compositions, and methods related thereto |
| 04/26/2006 | EP1648364A2 Pharmaceutical compositions for topical application |
| 04/26/2006 | EP1648299A1 Remote detection of substance delivery to cells |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1435916B1 Powder processing with pressurized gaseous fluids |
| 04/26/2006 | EP1424997A4 Amino acid modulated extended release dosage form |
| 04/26/2006 | EP1402039B1 MUTANT FORMS OF EtxB AND CtxB AND THEIR USE AS CARRIERS |
| 04/26/2006 | EP1320710B1 Drying method for selectively removing volatile components from wet coatings |
| 04/26/2006 | EP1259226B1 Anaesthetic formulations |
| 04/26/2006 | EP1255535B1 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 04/26/2006 | EP1240215B1 Method for the emulsion polymerisation of olefins |
| 04/26/2006 | EP0977562B8 Methods and compositions for delivery of taxanes |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 04/26/2006 | EP0841949B1 Use of saccharide conjugates |
| 04/26/2006 | CN1764602A Surface-modified titanium dioxide fine particles and dispersion comprising the same, and method for producing the same |
| 04/26/2006 | CN1764478A Anti-cancer anthracycline drug-antibody conjugates |
| 04/26/2006 | CN1764477A Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 04/26/2006 | CN1764461A Estradiol metabolites for the treatment of pulmonary hypertension |
| 04/26/2006 | CN1764452A Oral suspension of tegaserod |
| 04/26/2006 | CN1762990A Valency platform molecules comprising aminooxy groups |
| 04/26/2006 | CN1762495A Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
| 04/26/2006 | CN1762494A Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent |
| 04/26/2006 | CN1762489A Tf-SOD conjugate and its preparation process |
| 04/26/2006 | CN1762487A IL-2 precursor liposome and its preparation method |
| 04/26/2006 | CN1762453A Essential oil of 'Shiquan Dabu Wan', namely beta-cyclodextrin inclusion compound and its preparation process |
| 04/26/2006 | CN1762381A Ophthalmic compositions containing galactomannan polymers and borate |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762343A EGCG-zinc complex solid dispersion, its preparation method and application |
| 04/26/2006 | CN1762335A Rapidly disintegrating methylcellulose tablets |
| 04/26/2006 | CN1762334A Medicinal cooling emulsions |
| 04/26/2006 | CN1762333A Microemulsion formulation and its preparation process |
| 04/26/2006 | CN1762332A Temperature-controllable thermotherapeutic embolize micro-sphere and preparation method thereof |
| 04/26/2006 | CN1762331A Skeleton pattern medicine film encapsulated alimentary tract stent |
| 04/26/2006 | CN1762330A Medicine-loading sustained-releasing nanosphere alimentary tract stent |
| 04/26/2006 | CN1253528C Desiccation compositions containing hydrophobic amino acid |
| 04/26/2006 | CN1253220C Intradermal delivery of vaccines and gene therapeutic agents via microcannula |
| 04/26/2006 | CN1253209C Heat-resistant lyophilized protectant of lyophilized vaccine for henpox and preparing process thereof |
| 04/26/2006 | CN1253207C Split enveloped virus preparation |
| 04/26/2006 | CN1253206C Method for obtaining antigenic aggregates and use thereof in formulations |
| 04/26/2006 | CN1253149C Percutaneously absorbable patches |
| 04/26/2006 | CN1253148C Granules based on starch and lactose |
| 04/26/2006 | CN1253147C Ultra porous hydrogel complex substance, preparing method and use in pharmaceutics thereof |
| 04/26/2006 | CN1253099C Taste modifiers comprising chlorogenic acid |
| 04/25/2006 | USRE39079 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034160 Anticoagulants, methyl (2R,3R)-2-(3-(amino(imino)methyl)benzyl)-3-((4-(1-oxido-4-pyridinyl) benzoyl)amino)butanoate; therapeutic treatment of cardiovascular disorders |
| 04/25/2006 | US7034127 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 04/25/2006 | US7034121 Antibodies against CTLA4 |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7034083 Pressure-sensitive adhesive and patch employing the same |
| 04/25/2006 | US7034061 Anticoagulants; coatings for medical equipment containing polyether and heparin compound |
| 04/25/2006 | US7034019 Prodrugs of HIV replication inhibiting pyrimidines |
| 04/25/2006 | US7034014 Phosphonate compounds |
| 04/25/2006 | US7034013 Injectable sedative; mixture of propofol and sulfonated cyclodextrin |
| 04/25/2006 | US7034006 Use of lipid conjugates in the treatment of disease |
| 04/25/2006 | US7034001 Methods of therapy with thrombin derived peptides |
| 04/25/2006 | US7033998 Alcohol-free transdermal insulin composition and processes for manufacture and use thereof |
| 04/25/2006 | US7033992 Formulations for IL-11 |
| 04/25/2006 | US7033834 Comprise the gene of interest; and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; use in gene therapy |
| 04/25/2006 | US7033765 targeting sodium ion channel proteins; tissue-targeted therapy |
| 04/25/2006 | US7033623 Mineral absorption enhancer |
| 04/25/2006 | US7033620 High speed heating; controlling temperature; mixing with antioxidant; cooling |
| 04/25/2006 | US7033609 Microparticle preparation |
| 04/25/2006 | US7033607 Gene therapy; complexing nucleic acid and polymer |
| 04/25/2006 | US7033605 performing an ocular transplant procedure; implanting in the eye a biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer. |
| 04/25/2006 | US7033603 Tissue engineering; drug delivery; fiber with hollow bore |
| 04/25/2006 | US7033600 Inverse latex and use in cosmetics |
| 04/25/2006 | US7033599 Injectable compositions for the controlled delivery of pharmacologically active compound |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/25/2006 | US7033594 Method of treatment using ligand-immunogen conjugates |
| 04/25/2006 | US7033593 Immunogen comprising an HIV envelope protein, a ligand and H2 peptide |
| 04/25/2006 | US7033588 combination of coenzyme Q and a surfactant can prevent ascites even when administering in a small dose and within a short period of time |
| 04/25/2006 | US7033583 A water soluble polymer conjugated drug containing mercaptan group; controlled pharmacokinetics and improved bioavailability, relative to unmodified bioactive materials |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/25/2006 | US7033575 Delivery of physiologically active compounds through an inhalation route |
| 04/25/2006 | US7033574 Stable microbubbles suspensions injectable into living organisms |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | US7033571 Multiple stimulus reversible hydrogels |
| 04/25/2006 | US7032601 Encapsulated materials |
| 04/25/2006 | CA2438097C Cannabinoids pharmaceutical formulations |
| 04/25/2006 | CA2288429C Pegylation of polypeptides |
| 04/25/2006 | CA2265766C Rapidly disintegrating pellets |
| 04/25/2006 | CA2264687C Permeation enhancers for transdermal drug delivery compositions, devices, and methods |
| 04/25/2006 | CA2126929C Non-reducing oligosaccharide and its production and use |
| 04/20/2006 | WO2006042324A2 Antifungal composition applicable to body tissue, preferably nails |
| 04/20/2006 | WO2006041967A1 Method of formation of the shape-retentive aggregates of gel particles and their uses |
| 04/20/2006 | WO2006041878A2 Primary examiner |
| 04/20/2006 | WO2006041641A2 Therapeutic agents with decreased toxicity |
| 04/20/2006 | WO2006041192A1 Medicinal compositions containing apoptosis inducer |